| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |